Page results
-
This page describes a surgical keyhole procedure to remove fibroids, called a laparoscopic myomectomy.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
EMIS outage caused backlog of result messages via Keystone
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
-
Information about hyperthermic intraperitoneal chemotherapy (HIPEC), including about the risks and benefits, and alternatives to the treatment.
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0559 - Proton Beam Therapy contract
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0576 - Medications within dermatology
-
FOI/2022/0577 - Injuries relating to e-scooters, cycling and moterbikes
-
FOI/2022/0578 - Nurses and junior doctors sick leave for anxiety, stress, depression
-
FOI/2022/0585 - Racial abuse by patients towards staff